UCB's Global Corporate Website

Parcopa® (carbidopa, levodopa)

 

Back to the Clinical Study Index

 

Disease area
studied
Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Parkinson's Disease A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease Phase 3 SP0780
Completed
NCT00139867 PDF    
Parkinson's Disease A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease Phase 3 SP0867
Completed
NCT00139880 PDF